Risk Of Developing Liver Cancer After HCV Treatment

Sunday, November 7, 2010

AASLD Best Of The Liver Meeting:Treatment Hepatitis C 2010

The Best of The Liver Meeting® lets you catch up with what you missed at the meeting and enables you to revisit a session. All of the sessions are presented with audio and synchronized slide presentations.

Below is a list of The Best of The Liver Meeting® 2010 sessions.

Waiting For Hepatitis Debrief : Note The captured session has been delayed due to prepublication data issues and AASLD is working to rectify the issue.

In Case You Missed It :
Hans Popper Basic Science State-of-the-Art Lecture
Bile Acid Signaling: A Journey from the Nucleus to the Cell Membrane


Johan Auwerx, MD, PhD
Thomas E. Starzl Transplant Surgery State-of-the-Art Lecture
Hepatobiliary Neoplasia -- Is Transplantation the Answer?

Michael M. Abecassis, MD
Hyman J. Zimmerman Hepatotoxicity Lecture
The Good, the Bad, and the Ugly: Innate Immunity in Liver Injury

Gyongyi Szabo, MD, PhD
Leon Schiff State-of-the-Art Lecture
Genetics and Personalized Medicine for the Treatment of Hepatitis C

Added Dec 2

General Hepatology Update

Infectious Complications of Cirrhosis/Guadalupe Garcia-Tsao, MD

Iron Overload/Kyle Brown, MD

Vitamin D and Statins/Naga P. Chalasani, MD

Emerging Trends in Imaging Liver Disease


Imaging to Assess Progression of Chronic Liver Disease/Scott Reeder, MD, PhD

Imaging of Masses in Cirrhotic Liver/Bachir Taouli, MD

Imaging of Masses in Non-Cirrhotic Liver /Claude B. Sirlin, MD

Measuring HPVG Correctly/Juan Carlos Garcia-Pagan, MD

Global Forum

Understanding the Global Burden of Liver Disease/ Steven Wiersma, MD

North American Perspective/Hashem B. El-Serag, MD

European Perspective/Mark R. Thursz

Latin American Perspective/Martin Padilla, MD

Asian Perspective/Shiv K. Sarin, MD

African Perspective/Ayman Yosry, MD

Advances for Practitioners

Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype I Infection
Donald M. Jensen, MD

Genetic Variation in IL28B Predicts Hepatitis C Treatment-induced Viral Clearance
Gary L. Davis, MD

Epidemiology of Hepatitis E Virus in the United States: Results from the Third National Health and Nutrition Examination Survey
Marc G. Ghany, MD

Nov 23 Update Hepatitis B Talking Slides From AASLD

Direct Link To AASLD

*Free Registration May Be Required To View Video Presentation

Additional Information on the liver meeting

AASLD 2010 Summary Of Hepatitis C Oral Inhibitors
AUDIO AASLD Viral Hepatitis:Confronting a Silent Epidemic 2010
AUDIO AASLD:Hepatitis C/HBV/PIs Boceprevir/Telaprevir

Blog:AASLD available data

No comments:

Post a Comment